Oral immunotherapy for peanut allergy: Multipractice experience with epinephrine-treated reactions

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 1, 2014, Pages 91-96.e2

  Wasserman, Richard L ^a   Factor, Jeffrey M ^b   Baker, James W ^c   Mansfield, Lyndon E ^d   Katz, Yitzhak ^e   Hague, Angela R ^f   Paul, Marianne M ^c   Sugerman, Robert W ^a   Lee, Jason O ^b   Lester, Mitchell R ^b   Mendelson, Louis M ^b   Nacshon, Liat ^g   Levy, Michael B ^g   Goldberg, Michael R ^g   Elizur, Arnon ^e  

^a Medical City Children's Hospital   (United States)

^b Farmington   (United States)

^c LEGACY EMANUEL HOSPITAL   (United States)

^d Paul L Foster School of Medicine   (United States)

^e TEL AVIV UNIVERSITY   (Israel)

^f DallasAllergyImmunology   (United States)

^g Asaf Harofe Medical Center   (Israel)

Author keywords

Food allergy; Food allergy treatment; Oral immunotherapy; Peanut

Indexed keywords

ADRENALIN;

ABDOMINAL PAIN; ADULT; ALLERGIC REACTION; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; FOOD; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORAL IMMUNOTHERAPY; ORAL PRURITUS; OUTCOME ASSESSMENT; PATIENT SAFETY; PEANUT; PEANUT ALLERGY; PEANUT BUTTER; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SKIN DISEASE; VOMITING;

AMS; AVOIDANCE MANAGEMENT STRATEGY; EPINEPHRINE-TREATED REACTION; ETR; FOOD ALLERGY; FOOD ALLERGY TREATMENT; INSTITUTIONAL REVIEW BOARD; IRB; OIT; ORAL IMMUNOTHERAPY; PEANUT; PEANUT ORAL IMMUNOTHERAPY; PEANUT PROTEIN; POIT; PP; SCIT; SKIN PRICK TEST; SPT; SUBCUTANEOUS IMMUNOTHERAPY;

ADMINISTRATION, ORAL; ADRENERGIC AGONISTS; ALLERGENS; ANAPHYLAXIS; ARACHIS HYPOGAEA; DESENSITIZATION, IMMUNOLOGIC; EPINEPHRINE; HUMANS; ISRAEL; PEANUT HYPERSENSITIVITY; PLANT PROTEINS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84891648438     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.10.001     Document Type: Article

References (53)

1. Branum A.M., Lukacs S.L. Food allergy among children in the United States. Pediatrics 2009, 124:1549-1555.
2. Yunginger J.W., Squillace D.L., Jones R.T., Helm R.M. Fatal anaphylactic reactions induced by peanuts. Allergy Proc 1989, 10:249-253.
3. Herbert L.J., Dahlquist L.M. Perceived history of anaphylaxis and parental overprotection, autonomy, anxiety, and depression in food allergic young adults. J Clin Psychol Med Settings 2008, 15:261-269.
4. King R.M., Knibb R.C., Hourihane J.O. Impact of peanut allergy on quality of life, stress and anxiety in the family. Allergy 2009, 64:461-468.
5. Ostblom E., Egmar A.C., Gardulf A., Lilja G., Wickman M. The impact of food hypersensitivity reported in 9-year-old children by their parents on health-related quality of life. Allergy 2008, 63:211-218.
6. Akeson N., Worth A., Sheikh A. The psychosocial impact of anaphylaxis on young people and their parents. Clin Exp Allergy 2007, 37:1213-1220.
7. Bollinger M.E., Dahlquist L.M., Mudd K., Sonntag C., Dillinger L., McKenna K. The impact of food allergy on the daily activities of children and their families. Ann Allergy Asthma Immunol 2006, 96:415-421.
8. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010, 126:S1-S58.
9. Vander Leek T.K., Liu A.H., Stefanski K., Blacker B., Bock S.A. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 2000, 137:749-755.
10. Levy M.B., Goldberg M.R., Nachshon L., Tabachnik E., Katz Y. Lessons from cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen. Isr Med Assoc J 2012, 14:29-33.
11. Young M.C., Munoz-Furlong A., Sicherer S.H. Management of food allergies in schools: a perspective for allergists. J Allergy Clin Immunol 2009, 124:175-182. 182.
12. Lieberman J.A., Weiss C., Furlong T.J., Sicherer M., Sicherer S.H. Bullying among pediatric patients with food allergy. Ann Allergy Asthma Immunol 2010, 105:282-286.
13. Muñoz-Furlong A. Daily coping strategies for patients and their families. Pediatrics 2003, 111:1654-1661.
14. Bock S.A., Muñoz-Furlong A., Sampson H. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007, 119:1016-1018.
15. Clark S., Espinola J., Rudders S.A., Banerji A., Camargo C.A. Frequency of US emergency department visits for food-related acute allergic reactions. J Allergy Clin Immunol 2011, 127:682-683.
16. Nguyen-Luu N.U., Ben-Shoshan M., Alizadehfar R., Joseph L., Harada L., Allen M., et al. Inadvertent exposures in children with peanut allergy. Pediatr Allergy Immunol 2012, 23:133-139.
17. Bock S.A., Munoz-Furlong A., Sampson H.A. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001, 107:191-193.
18. Gold M., Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (Epipen). J Allergy Clin Immunol 2000, 106:171-176.
19. Simmons F.E.R., Clark S., Camargo C.A. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009, 124:301-306.
20. Nowak-Wegrzyn A., Sampson H.A. Future therapies for food allergies. J Allergy Clin Immunol 2011, 127:558-573.
21. Edwards H.E. Oral desensitization in food allergy. Can Med Assoc J 1940, 40:234-236.
22. Mansfield L. Successful oral desensitization for systemic peanut allergy. Ann Allergy Asthma Immunol 2006, 97:266-267.
23. Anagnostou K., Clark A., King Y., Islam S., Deighton J., Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 2011, 41:1273-1281.
24. Yu G.P., Weldon B., Neale-May S., Nadeau K.C. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial. Int Arch Allergy Immunol 2012, 159:179-182.
25. Sheikh A., Nurmatov U., Venderbosch I., Bischoff E. Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies. Prim Care Respir J 2012, 21:41-49.
26. Hofmann A.M., Scurlock A.M., Jones S.M., Palmer K.P., Lokhnygina Y., Steele P.H., et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009, 124:286-291. 291.e1-6.
27. Fleischer D.M., Burks A.W., Vickery B.P., Scurlock A.M., Wood R.A., Jones S.M., et al. Consortium of Food Allergy Research (CoFAR). Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013, 131:119-127. e1-7.
28. Harvey S.M., Laurie S., Hilton K., Khan D.A. Safety of rush immunotherapy to multiple aeroallergens in an adult population. Ann Allergy Asthma Immunol 2004, 92:414-419.
29. Parmiani S., Fernandez Tavora L., Moreno C., Guardia P., Rico P. Clustered schedules in allergen specific immunotherapy. Allergol Immunopathol (Madr) 2002, 30:283-291.
30. Thyagarajan A., Varshney P., Jones S.M., Sicherer S., Wood R., Vickery B.P., et al. Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol 2010, 126:31-32.
31. Meglio P., Bartone E., Plantamura M., Arabito E., Giampietro P.G. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004, 59:980-987.
32. Cox L., Nelson H., Lockey R., Calabria C., Chacko T., Finegold I., et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011, 127(Suppl):S1-55. Erratum in: J Allergy Clin Immunol 2011;127:840.
33. Sampson H.A., Ho D.G. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997, 100:444-451.
34. Varshney P., Steele P.H., Vickery B.P., Bird A.J., Thyagarajan A., Scurlock A.M., et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allerg Clin Immunol 2009, 124(6):1351-1352.
35. Mulla Z.D., Simon M.R. Hospitalizations for anaphylaxis in Florida: epidemiologic analysis of a population-based dataset. Int Arch Allergy Immunol 2007, 144:128-136.
36. Ross M.P., Ferguson M., Street D., Klontz K., Schroeder T., Luccioli S. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy Clin Immunol 2008, 121:166-171.
37. Decker W.W., Campbell R.L., Manivannan V., Luke A., St Sauver J.L., Weaver A., et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008, 122:1161-1165.
38. Lin R.Y., Anderson A.S., Shah S.N., Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006. Ann Allergy Asthma Immunol 2008, 101:387-393.
39. Roy K.M., Roberts M.C. Peanut allergy in children relationships to health-related quality of life, anxiety, and parental stress. Clin Pediatr 2011, 50:1045-1051.
40. Hullmann S.E., Molzon E.S., Eddington A.R., Mullins L.L. Dating anxiety in adolescents and young adults with food allergies: a comparison to healthy peers. J Asthma Allergy Ed 2012, 3:172-177.
41. Lyons A.C., Forde E.M.E. Food allergy in young adults: perceptions and psychological effects. J Health Psychol 2004, 9:497-504.
42. Cummings A.J., Knibb R.C., King R.M., Lucas J.S. The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 2010, 65:933-945.
43. Cohen B.L., Noone S., Munoz-Furlong A., Sicherer S.H. Development of a questionnaire to measure quality of life in families with a child with food allergy. J Allergy Clin Immunol 2004, 114:1159-1163.
44. Allen K.J., O'Hehir R.E. The evolution of oral immunotherapy for the treatment of peanut allergy. Clin Exp Allergy 2011, 41:1172-1174.
45. Varshney P., Jones S.M., Scurlock A.M., Perry T.T., Kemper A., Steele P., et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011, 127:654-660.
46. Phillips J.F., Lockey R.F., Fox R.W., Ledford D.K., Glaum M.C. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. Allergy Asthma Proc 2011, 32:288-294.
47. Bernstein D.I., Blaiss M.S., Cox L.S., Feingold I., Lanier R.Q., Nelson H.S., et al. Current standards and future directions in immunotherapy: perspectives on challenges. Ann Allergy Asthma Immunol 2010, 104:530-535.
48. Neuman-Sunshine D.L., Eckman J.A., Keet C.A., Matsui E.C., Peng R.D., Lenehan P.J., et al. The natural history of persistent peanut allergy. Ann Allergy Asthma Immunol 2012, 108:326-331.
49. Fleischer D.M., Perry T.T., Atkins D., Wood R.A., Burks A.W., Jones S., et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics 2012, 130:e25-e32.
50. Sampson H.A., Mendelson L., Rosen J.P. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992, 327:380-384.
51. Hague A.R., Wasserman R.L., Sugerman R.W. Food Allergy Quality of Life (FAQOL) Is Improved For Food Oral Immunotherapy (OIT) Treated Patients and Their Families. J Allergy Clin Immunol 2012, 129(Supplement):AB29.
52. Factor J.M., Mendelson L.M., Lee J.O., Nouman G., Lester M.R. Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol 2012, 109:348-352.
53. Keet C.A., Seopaul S., Knorr S., Narisety S., Skripak J., Wood R.A. Long-term follow-up of oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2013, 132:737-739. e6.